Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Organogenesis Holdings Inc. - Class A (NQ:ORGO)

4.765 -0.155 (-3.15%)
Streaming Delayed Price Updated: 2:13 PM EST, Dec 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Organogenesis Holdings Inc. - Class A

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Organogenesis Holdings: Q2 Earnings Insights ↗
Shares of Organogenesis Holdings (NASDAQ:ORGO) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 400.00% year over... 
Via Benzinga
News headline image
Organogenesis Holdings Insights: Return On Capital Employed ↗
Organogenesis Holdings (NASDAQ:ORGO) posted Q1 earnings of $12.62 million, an increase from Q4 of 42.05%. Sales dropped to $102.55 million, a 3.98% decrease between quarters. In... 
Via Benzinga
News headline image
Looking Into Organogenesis Holdings's Return On Capital Employed ↗
Looking at Q1, Organogenesis Holdings (NASDAQ:ORGO) earned $12.62 million, a 42.05% increase from the preceding quarter. Organogenesis Holdings's sales decreased to $102.55... 
Via Benzinga
News headline image
3 Biotech Stocks Wall Street Predicts Will Rally By 45% Or More ↗
Wall Street analysts expect the biotech industry to grow significantly soon, with the biotech stocks Organogenesis (ORGO​​​​​​​), BioDelivery Sciences (BDSI) and Champions Oncology (CSBR) gaining more... 
Via Talk Markets
News headline image
Why Organogenesis Holdings Blasted 7.7% Higher Today ↗
The company will be a component of a high-profile stock index. 
Via The Motley Fool
Topics Stocks
News headline image
41 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers 1847 Goedeker Inc. (NYSE: GOED) shares jumped 156.5% to $11.08 after dropping over 8% on Wednesday. Vertex Energy, Inc. (NASDAQ: VTNR) jumped 117% to $3.8604 after the... 
Via Benzinga
News headline image
Earnings Scheduled For August 9, 2021 ↗
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
News headline image
60 Biggest Movers From Yesterday ↗
Gainers Vertex Energy, Inc. (NASDAQ: VTNR) shares climbed 124.2% to settle at $3.99 on Thursday after the company announced plans to acquire a Alabama refinery and related... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers Zosano Pharma (NASDAQ:ZSAN) stock moved upwards by 22.59% to $0.91 during Thursday's pre-market session. The company's market cap stands at $97.3 million.... 
Via Benzinga
News headline image
Earnings Scheduled For May 10, 2021 ↗
Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Highs On Friday ↗
During the morning session on Friday, 178 stocks hit new 52-week highs. Noteworthy Points: Microsoft (NASDAQ:MSFT) was the largest firm on a market cap basis to set... 
Via Benzinga
News headline image
24 Stocks Moving in Thursday's Pre-Market Session ↗
Gainers Vertex Energy, Inc. (NASDAQ: VTNR) rose 82% to $3.24 in pre-market trading after the company announced plans to acquire a Alabama refinery and related logistics assets.... 
Via Benzinga
News headline image
Organogenesis Holdings Inc (ORGO) Q1 2021 Earnings Call Transcript ↗
ORGO earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Organogenesis Holdings: Q1 Earnings Insights ↗
Shares of Organogenesis Holdings (NASDAQ:ORGO) increased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 143.75% year over... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Gainers Vir Biotechnology (NASDAQ:VIR) sha... 
Via Benzinga
News headline image
Earnings Outlook for Organogenesis Holdings ↗
Organogenesis Holdings (NASDAQ:ORGO) releases its next round of earnings this Monday, May 10. Here is Benzinga's essential guide to Organogenesis Holdings's Q1 earnings report.... 
Via Benzinga
News headline image
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers Obalon Therapeutics (NASDAQ:OBLN)... 
Via Benzinga
News headline image
Repligen Stock Gets Relative Strength Rating Upgrade With Earnings Due ↗
A Relative Strength Rating upgrade for Repligen shows improving technical performance. Will it continue? 
Via Investor's Business Daily
News headline image
Medical Device Maker Quanterix Sees Relative Strength Rating Rise To 86 ↗
On Tuesday, Quanterix stock hit an important technical milestone, with its Relative Strength (RS) Rating rising into to 86, up from 80 the day before. 
Via Investor's Business Daily
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Gainers Reviva Pharmaceuticals (NASDAQ:RVPH) shares rose 72.91% to $7.47 during Monday's regular session. Reviva Pharmaceuticals's stock is trading at a volume of... 
Via Benzinga
News headline image
Align Technology Nears Buy Point With Earnings Due ↗
Align Technology is near a possible buy zone ahead of its next quarterly earnings report, expected on or around April 28. 
Via Investor's Business Daily
News headline image
Cancer Therapy Novocure Stock Still On A High As It Clears Technical Benchmark ↗
Cancer therapy Novocure stock had its Relative Strength (RS) Rating upgraded from 90 to 93 Wednesday. It's also an IBD 50 member. 
Via Investor's Business Daily
News headline image
Cancer Therapy Novocure Stock Flashes Renewed Technical Strength ↗
Novocure stock saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 67 to 92. 
Via Investor's Business Daily
News headline image
The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 8) Aclaris Therapeutics, Inc... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.